(Q45306085)

11 December 2017

Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington's disease transgenic mice (English)

1 reference

11 December 2017

0 references

A Wallace Deckel

1

1 reference

11 December 2017

Vinsee Tang

2

1 reference

11 December 2017

Diane Nuttal

3

1 reference

11 December 2017

Keith Gary

4

1 reference

11 December 2017

Robert Elder

5

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

11 December 2017

1 reference

11 December 2017

939

1 reference

11 December 2017

1-2

1 reference

11 December 2017

76-86

1 reference

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

High blood levels of nitric oxide in rats subjected to prolonged respiratory arrest and their modulation during adrenocorticotropin-induced resuscitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Sustained attenuation of the cerebrovascular response to a 10 min whisker stimulation following neuronal nitric oxide synthase inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Endogenous nitric oxide synthesis: biological functions and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Nitric oxide in neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Nitric oxide and nitric oxide synthase in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Cerebral blood flow velocity decreases during cognitive stimulation in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Vasomotor hyporeactivity in the anterior cerebral artery during motor activation in Huntington's disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of L-NAME on symptom progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Mechanisms of cell death governed by the balance between nitrosative and oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Selective sparing of a class of striatal neurons in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Regulation of neuronal nitric-oxide synthase by calmodulin kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Plasticity of NO synthase expression in the nervous and endocrine systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Nitric oxide synthase-independent generation of nitric oxide in rat skeletal muscle ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Huntington's disease. Pathogenesis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Inhibition by calmodulin antagonists of the neurogenic relaxation in cerebral arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

The CaM-kinase II inhibitor KN-62 blocks NMDA but not kainate stimulation of NO synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Hypoxia influences enkephalin release in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Dynamic regulation of neuronal NO synthase transcription by calcium influx through a CREB family transcription factor-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Calmodulin-dependent protein kinase II potentiates transcriptional activation through activating transcription factor 1 but not cAMP response element-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

7 January 2021

Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Antioxidant effects of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Calmodulin kinase II attenuation of gene transcription by preventing cAMP response element-binding protein (CREB) dimerization and binding of the CREB-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Pathology of CAG repeat diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Modulation of LTP induction by NMDA receptor activation and nitric oxide release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Oxidative stress in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(02)02550-7

1 reference

11 December 2017

1 reference